SLU-PP-332
Metabolic (non-peptide) · By Preptide Pro editorial team · Last updated
SLU-PP-332 is a metabolic (non-peptide) peptide, and it is not FDA-approved. A small-molecule ERR agonist studied as an 'exercise mimetic', not a peptide. Research so far is in animals.
Not FDA-approvedChemistry (PubChem)
| PubChem CID | 5338394 |
|---|---|
| CAS number | 303760-60-3 |
| Molecular formula | C18H14N2O2 |
| Molecular weight | 290.3 g/mol |
| Other names | SLU-PP-332, MFCD00595076, ERR pan-Agonist 332, GLXC-27127, EX-A17557, SR9861, STK082756, ZINC33296329 |
Is SLU-PP-332 FDA-approved?
Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).
How much research is there on SLU-PP-332?
PubMed lists 10 records for “SLU-PP-332”, of which 0 are tagged as human clinical trials.
| Recent study | Journal | Date |
|---|---|---|
| In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential. | Rapid Commun Mass Spectrom | 2026 Apr 30 |
| Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling. | Int J Biol Macromol | 2026 Apr |
| Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes. | Drug Test Anal | 2026 Mar |
| [Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications]. | Rev Med Chil | 2026 Feb |
| An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity. | J Pharmacol Exp Ther | 2026 Jan |
Sources
This is general research information, not medical advice. Check with a clinician before using any compound.